Perform Another (Advanced) Search

1. Clinical Trial Results: Hepatitis D, Chronic
...Clinical Trial Results: Hepatitis D, Chronic Clinical Trial Results: Hepatitis D, Chronic Product Name: PEGASYS [peginterferon alfa-2a (40KD)] Date ...
View Page

2.  Study Posting (4519) Trial #124803, Hepatitis, Timisoara, Romania
...Romania Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis D (CHD) Status: No longer recruiting Protocol Number: ML18788 Sponsor: Roche Romania Company Division: Pharmaceutical Official ...
View Page

3.  Study Posting (4519) Trial #124788, Hepatitis, Iasi, Romania
...Romania Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis D (CHD) Status: No longer recruiting Protocol Number: ML18788 Sponsor: Roche Romania Company Division: Pharmaceutical Official ...
View Page

4.  Study Posting (4519) Trial #124775, Hepatitis, Craiova, Romania
...Romania Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis D (CHD) Status: No longer recruiting Protocol Number: ML18788 Sponsor: Roche Romania Company Division: Pharmaceutical Official ...
View Page

5.  Study Posting (4519) Trial #125465, Hepatitis, Constanta, Romania
...Romania Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis D (CHD) Status: No longer recruiting Protocol Number: ML18788 Sponsor: Roche Romania Company Division: Pharmaceutical Official ...
View Page

6.  Study Posting (4519) Trial #124772, Hepatitis, Cluj-Napoca, Romania
...Romania Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis D (CHD) Status: No longer recruiting Protocol Number: ML18788 Sponsor: Roche Romania Company Division: Pharmaceutical Official ...
View Page

7.  Study Posting (4519) Trial #122612, Hepatitis, Bucharest, Romania
...Romania Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis D (CHD) Status: No longer recruiting Protocol Number: ML18788 Sponsor: Roche Romania Company Division: Pharmaceutical Official ...
View Page

8.  Study Posting (4519) Trial #124366, Hepatitis, Cagliari, Italy
...Study of PEGASYS (Peginterferon alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis D (CHD) Status: No longer recruiting Protocol Number: ML18149 Sponsor: Roche S.p.A. Company Division ...
View Page

9. Clinical Trial Results by Drug Names
...Title of Study: A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis D (CHD) Fast Facts: Protocol number: ML18788 Sponsor: Roche Romania Company division: Pharmaceutical Product name: PEGASYS ...
View Page

10. Clinical Trial Results by Drug Names
...Study of PEGASYS (Peginterferon Alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis D (CHD). Fast Facts: Protocol number: ML18149 Sponsor: Roche S.p.A. Company division: Pharmaceutical Product ...
View Page

11.  CenterWatch: Clinical Trials in Category (79) Hepatitis
...Study of PEGASYS (Peginterferon alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis D (CHD) Romania Bucharest : Research Site: A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients ...
View Page

12.  Study Posting (77) Trial #111015, Hepatitis, Manhasset, NY
...interferon or other immuno-stimulators in the last 24 weeks • Have HIV, hepatitis C or hepatitis D • Are pregnant, breastfeeding or intend to become pregnant during the study • Have a history of ...
View Page

13. Clinical Trial Results by Medical Conditions
...7) • Heart Transplantation (5) • Hematologic Neoplasms (1) • Hepatitis B, Chronic (26) • Hepatitis C, Chronic (72) • Hepatitis D, Chronic (2) • HIV Infections (37) • Human Papilloma Virus (HPV) (1) • Hypertension (High Blood Pressure) (1 ...
View Page

14.  Study Posting (4519) Trial #157404, Hepatitis B, Hong Kong, Hong Kong
...or immunomodulatory treatment in previous 6 months; • co-infection with active hepatitis A, hepatitis C, hepatitis D or HIV; • history or other evidence of a medical condition associated with chronic liver disease ...
View Page

15.  Study Posting (4519) Trial #147411, Hepatitis B, Villejuif, France
...copies/mL. Exclusion Criteria: • interferon-based treatment in past 6 months; • coinfection with hepatitis C, hepatitis D or HIV; • liver cirrhosis, decompensated liver disease, or hepato-cellular carcinoma. Gender: Males or Females ...
View Page

16.  Study Posting (4519) Trial #147409, Hepatitis B, Toulouse, France
...copies/mL. Exclusion Criteria: • interferon-based treatment in past 6 months; • coinfection with hepatitis C, hepatitis D or HIV; • liver cirrhosis, decompensated liver disease, or hepato-cellular carcinoma. Gender: Males or Females ...
View Page

17.  Study Posting (4519) Trial #125793, Hepatitis B, Saint Laurent Du Var, France
...copies/mL. Exclusion Criteria: • interferon-based treatment in past 6 months; • coinfection with hepatitis C, hepatitis D or HIV; • liver cirrhosis, decompensated liver disease, or hepato-cellular carcinoma. Gender: Males or Females ...
View Page

18.  Study Posting (4519) Trial #147854, Hepatitis B, Pessac, France
...copies/mL. Exclusion Criteria: • interferon-based treatment in past 6 months; • coinfection with hepatitis C, hepatitis D or HIV; • liver cirrhosis, decompensated liver disease, or hepato-cellular carcinoma. Gender: Males or Females ...
View Page

19.  Study Posting (4519) Trial #123013, Hepatitis B, Paris, France
...copies/mL. Exclusion Criteria: • interferon-based treatment in past 6 months; • coinfection with hepatitis C, hepatitis D or HIV; • liver cirrhosis, decompensated liver disease, or hepato-cellular carcinoma. Gender: Males or Females ...
View Page

20.  Study Posting (4519) Trial #124064, Hepatitis B, Orleans, France
...copies/mL. Exclusion Criteria: • interferon-based treatment in past 6 months; • coinfection with hepatitis C, hepatitis D or HIV; • liver cirrhosis, decompensated liver disease, or hepato-cellular carcinoma. Gender: Males or Females ...
View Page